Contact Information
37 Westminster Buildings, Theatre Square,
Nottingham, NG1 6LG
Pharmaceuticals
Could Scientist Find Drug to Treat His Own Disease?
How a researcher’s 12-year journey to a new Bristol-Myers psoriasis medicine became personal: “You have hopes and daydreams almost in some ways.” Source link
Weight-Loss Drug Wegovy Cuts Heart Risk in New Study
Novo Nordisk’s anti-obesity drug reduced people’s risk of suffering heart attacks, strokes and cardiovascular deaths by 20%. Source link
Drug Shortages Are a Boon to One Industry: Compounding Pharmacies
Hospitals increasingly rely on a sector that can start making drugs without FDA approval—and investment is pouring in. Source link
Pfizer’s Covid Boost Crashes to Earth
This copy is for your personal, non-commercial use only. Distribution and use of this material are governed by our Subscriber Agreement and by copyright law.
First Pill for Postpartum Depression Is Approved by FDA
The pill, to be taken daily for at least two weeks, significantly reduced postpartum depression among new mothers in a recent trial. Source link
Employers Cut Off Access to Weight-Loss Drugs for Workers
Costs are mounting for popular drugs such as Wegovy, a cousin of Ozempic, and healthcare plans are restricting coverage to save money. Source link
Venture Capitalist Seeks to Spur Drug Development for Rare Autoimmune Disease
Venture capitalist Luke Evnin has financed several successful biotechnology startups that develop treatments for cancer. Now he is encouraging drugmakers to tackle another disease: a rare autoimmune condition that
Pfizer Misses Revenue Expectations, Bets on Drug Launches to Ease Shortfall
The company is rolling out 19 products or new uses within 18 months, CEO Albert Bourla said. Source link
CVS to Shed 5,000 Jobs in Cost-Cutting Push
The healthcare giant wants to trim corporate roles and spending on travel and its use of consultants. Source link
Apple, Amazon, Starbucks to Report in Packed Earnings Week
Earnings reports also from Uber Technologies, Pfizer and Kraft Heinz are expected to shed light on how consumer spending is holding up amid rising interest